(Q44762371)

6 December 2017

title

Pilot study of recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of chronic hepatitis B. (English)

1 reference

Colony stimulating factor 2

6 December 2017

1 reference

1 reference

1 reference

J Martin

1

1 reference

6 December 2017

O Bosch

2

1 reference

6 December 2017

G Moraleda

3

1 reference

6 December 2017

J Bartolome

4

1 reference

6 December 2017

J A Quiroga

5

1 reference

6 December 2017

V Carreño

6

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 October 1993

1 reference

6 December 2017

1 reference

6 December 2017

volume

18

1 reference

6 December 2017

issue

4

1 reference

6 December 2017

page(s)

775-780

1 reference

Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180405

Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180405

7 January 2021

Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180405

7 January 2021

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180405

7 January 2021

Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180405

7 January 2021

Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180405

7 January 2021

Acyclovir in hepatitis B antigen-positive chronic liver disease: inhibition of viral replication and transient renal impairment with iv bolus administration.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180405

7 January 2021

Combination of recombinant interferons alpha and gamma in treatment of chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180405

7 January 2021

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180405

7 January 2021

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180405

7 January 2021

An assay for the detection of the DNA genome of hepatitis B virus in serum

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180405

7 January 2021

https://api.crossref.org/works/10.1002%2FHEP.1840180405

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.1840180405

1 reference

6 December 2017

1 reference